Figure 5.

Observed disease-specific survival (DSS) at 1, 2 and 3 years after hepatic resection versus mean nomogram predicted DSS stratified by peri-operative chemotherapy treatment for patients with follow-up after liver resection of at least 6 months. The 48 patients treated with peri-operative irinotecan or oxaliplatin are compared with the other 144 patients. The lines with error bars represent the performance of the Memorial-Sloan Kettering Cancer Center (MSKCC) nomogram applied to the Duke University Medical Center (DUMC) patients. The diagonal line represents the performance of an ideal nomogram